Acute liver failure after recommended doses of acetaminophen in patients with myopathies

Critical Care Medicine

Volumn 39, Issue 4, 2011, Pages 678-682

  Ceelie, Ilse ^a   James, Laura P ^b   Gijsen, Violette ^a,c   Mathot, Ron A A ^d   Ito, Shinya ^c   Tesselaar, Coranne D ^e,f   Tibboel, Dick ^a   Koren, Gideon ^c   De Wildt, Saskia N ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e AMPHIA HOSPITAL   (Netherlands)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

acetaminophen; acetaminophen adduct; acute liver failure; adverse event; myopathy; pediatrics

Indexed keywords

ACETYLCYSTEINE; AMOXICILLIN PLUS CLAVULANIC ACID; CEFUROXIME; CLARITHROMYCIN; DICLOFENAC; DIHYDROMORPHINE; FENTANYL; PARACETAMOL; PROPOFOL; PROTEIN; REMIFENTANIL; ROCURONIUM; SEVOFLURANE;

ABDOMINAL PAIN; ACUTE LIVER FAILURE; ADD ON THERAPY; ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BLOOD SAMPLING; BRAIN DISEASE; CARNITINE DEFICIENCY; CASE REPORT; CHILD; CLINICAL ASSESSMENT; CRITICALLY ILL PATIENT; DRUG BLOOD LEVEL; DRUG OVERDOSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEMATOTHORAX; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; JAUNDICE; LIVER FUNCTION TEST; LIVER INJURY; MULTIPLE ORGAN FAILURE; MUSCULAR DYSTROPHY; MYOPATHY; NAUSEA; PNEUMONIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECOMMENDED DRUG DOSE; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SCHOOL CHILD; SCOLIOSIS; SPINAL MUSCULAR ATROPHY; SPINE FUSION; VOMITING;

EID: 79953219731     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318206cc8f     Document Type: Article

References (33)

1. Kuehn BM: FDA focuses on drugs and liver damage: Labeling and other changes for acetaminophen. JAMA 2009; 302:369-371.
2. Watkins PB, Kaplowitz N, Slattery JT, et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: A randomized controlled trial. JAMA 2006; 296:87-93.
3. Squires RH Jr, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: The first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006; 148:652-658.
4. Patten CJ, Thomas PE, Guy RL, et al. Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol 1993; 6:511-518. (Pubitemid 23212521)
5. Dahlin DC, Miwa GT, Lu AY, et al. N-acetylp- benzoquinone imine: A cytochrome P-450- mediated oxidation product of acetaminophen. Proc Natl Acad Sci USA 1984; 81: 1327-1331. (Pubitemid 14173462)
6. James LP, Mayeux PR, Hinson JA: Acetaminophen- induced hepatotoxicity. Drug Metab Dispos 2003; 31:1499-1506.
7. Hinson JA, Pohl LR, Monks TJ, et al. Acetaminophen- induced hepatotoxicity. Life Sci 1981; 29:107-116.
8. Muldrew KL, James LP, Coop L, et al. Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxic doses of acetaminophen using high-performance liquid chromatography with electrochemical detection. Drug Metab Dispos 2002; 30:446-451. (Pubitemid 34263830)
9. James LP, Capparelli EV, Simpson PM, et al. Acetaminophen-associated hepatic injury: evaluation of acetaminophen protein adducts in children and adolescents with acetaminophen overdose. Clin Pharmacol Ther 2008; 84:684-690.
10. James LP, Letzig L, Simpson PM, et al. Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure. Drug Metab Dispos 2009; 37:1779-1784.
11. Danan G, Benichou C: Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol 1993; 46:1323-1330. (Pubitemid 23333873)
12. Benichou C, Danan G, Flahault A: Causality assessment of adverse reactions to drugs-II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge. J Clin Epidemiol 1993; 46:1331-1336. (Pubitemid 23333874)
13. Liss G, Lewis JH: Drug-induced liver injury: What was new in 2008? Expert Opin Drug Metab Toxicol 2009; 5:843-860.
14. Pearce B, Grant IS: Acute liver failure following therapeutic paracetamol administration in patients with muscular dystrophies. Anaesthesia 2008; 63:89-91. (Pubitemid 350233217)
15. Hynson JL, South M: Childhood hepatotoxicity with paracetamol doses less than 150 mg/kg per day. Med J Aust 1999; 171:497. (Pubitemid 29531109)
16. FDA: Joint Meeting of the Drug Safety and Risk Management Advisory Committee with the Anesthetic and Life Support Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee. 2008. Available at: http://www.fda.gov/advisorycommittees/ calendar/ucm143083.htm. Accessed July 6, 2010.
17. James LP, Simpson P, Russo M, et al. Detection of acetaminophen protein adducts in serum during therapeutic exposure to acetaminophen in healthy volunteers. In: The Liver Meeting 2007. Alexandria, VA, American Association for the Study of Liver Diseases, 2007.
18. Singhal S, Gray T, Guzman G, et al. Sevoflurane hepatotoxicity: A case report of sevoflurane hepatic necrosis and review of the literature. Am J Ther 2010; 17:219-222.
19. Fudickar A, Bein B: Propofol infusion syndrome: update of clinical manifestation and pathophysiology. Minerva Anestesiol 2009; 75:339-344.
20. Hwang J: Diets with corn oil and/or low protein increase acute acetaminophen hepatotoxicity compared to diets with beef tallow in a rat model. Nutr Res Pract 2009; 3:95-101.
21. Yoo JS, Park HS, Ning SM, et al. Effects of thiamine deficiency on hepatic cytochromes P450 and drug-metabolizing enzyme activities. Biochem Pharmacol 1990; 39:519-525. (Pubitemid 20041921)
22. Zemel BS, Riley EM, Stallings VA: Evaluation of methodology for nutritional assessment in children: Anthropometry, body composition, and energy expenditure. Annu Rev Nutr 1997; 17:211-235. (Pubitemid 27328799)
23. Khoshoo V: Nutritional assessment in children and adolescents. Curr Opin Pediatr 1997; 9:502-507. (Pubitemid 27490122)
24. Li J, Kaneko T, Wang Y, et al. Troglitazone enhances the hepatotoxicity of acetaminophen by inducing CYP3A in rats. Toxicology 2002, 176:91-100. (Pubitemid 34626733)
25. Kostrubsky SE, Sinclair JF, Strom SC, et al. Phenobarbital and phenytoin increased acetaminophen hepatotoxicity due to inhibition of UDP- glucuronosyltransferases in cultured human hepatocytes. Toxicol Sci 2005; 87: 146-155. (Pubitemid 41222666)
26. Suzuki A, Yuen N, Walsh J, et al. Co-medications that modulate liver injury and repair influence clinical outcome of acetaminophen- associated liver injury. Clin Gastroenterol Hepatol 2009; 7:882-888.
27. Tinel M, Descatoire V, Larrey D, et al. Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides. J Pharmacol Exp Ther 1989; 250:746-751. (Pubitemid 19216168)
28. Jaeschke H: Role of inflammation in the mechanism of acetaminophen- induced hepatotoxicity. Expert Opin Drug Metab Toxicol 2005; 1:389-397.
29. Neustadt J, Pieczenik SR: Medicationinduced mitochondrial damage and disease. Mol Nutr Food Res 2008; 52:780-788.
30. Jaeschke H, Bajt ML: Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci 2006; 89:31-41. (Pubitemid 43013752)
31. Yapar K, Kart A, Karapehlivan M, et al. Hepatoprotective effect of L-carnitine against acute acetaminophen toxicity in mice. Exp Toxicol Pathol 2007; 59:121-128. (Pubitemid 47405222)
32. Mancuso M, Orsucci D, Logerfo A, et al. Oxidative stress biomarkers in mitochondrial myopathies, basally and after cysteine donor supplementation. J Neurol 2010; 257:774-781.
33. Hinson JA, Roberts DW, James LP: Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol 2010; 369-405